Laura Chow, MD, Cancer Immunotherapy Trailblazer, Joins Summit as Senior Vice President of Clinical Development

Dr. Chow Brings Two Decades of Immunotherapy & Anti-Angiogenic Cancer Treatment Experience to Team Summit

...

Related Keywords

United Kingdom ,Texas ,United States ,Japan ,Colorado ,California ,Calgary ,Alberta ,Canada ,Menlo Park ,China ,University Of Texas ,Ottawa ,Ontario ,Australia ,British ,Jack West ,Allens Yang ,Robertw Duggan ,Laura Chow ,Fred Hutch ,University Of British Columbia ,Twitter ,Exchange Commission ,Clinical Development In Solid Tumors ,University Of Texas At Austin ,University Of Calgary ,Clinical Development ,University Of Alberta ,Akeso Inc ,Summit Therapeutic Mission Statement ,Drug Administration ,University Of Ottawa ,Summit Therapeutics Inc ,University Of Washington School Medicine ,Nasdaq ,Cancer Center ,Team Summit ,Clinical Research ,Lung Cancer Program At Dell Medical School ,University Of Washington ,University Of Colorado ,Summit Therapeutics ,Senior Vice President ,Chief Executive Officer ,Fate Therapeutics ,Vice President ,Associate Chair ,Oncology Education ,Lung Cancer Program ,Dell Medical School ,Associate Cancer Center Director ,Livestrong Cancer ,Washington School ,British Columbia ,Chief Medical Officer ,Lori Styles ,Nasdaq Global Market ,Private Securities Litigation Reform Act ,